Elevation Oncology, Inc. (NASDAQ:ELEV – Get Free Report) was the recipient of a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 4,630,000 shares, an increase of 28.3% from the February 29th total of 3,610,000 shares. Approximately 11.6% of the company’s shares are sold short. […]